Literature DB >> 31648010

Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients.

Arianna Vignini1, Sonila Alia2, Sofia Pugnaloni2, Alessia Giulietti2, Tiziana Bacchetti3, Laura Mazzanti2, Simona Luzzi4, Rosamaria Fiorini3.   

Abstract

Alzheimer's disease (AD) is the most common cause of dementia accounting for 60-70% of all demented cases and one of the leading sources of morbidity and mortality in the aging population. Most of the recent literature regards the relationship between plasma oxidative stress and AD, showing that markers of lipid peroxidation are significantly higher in AD and Mild Cognitive Impairment (MCI) patients with respect to control subjects. The increased generation of reactive oxygen species that occurs in AD may be also responsible for oxidative injury to erythrocyte membranes. Since erythrocyte membrane serves as a variable barrier to oxygen transport, changes in its stability can induce cellular hypoxia and the consequence brain tissue oxygenation. In this study, plasma oxygen radical absorbance capacity (ORAC) and erythrocyte membrane fluidity have been evaluated in control, MCI and AD patients. Moreover erythrocyte membrane acetylcholinesterase (AchE) activity has been measured in control and AD patients. Plasma ORAC significantly decreased in MCI and AD subjects with respect to the controls, while a decrease in erythrocyte membrane fluidity has been observed only in MCI patients. No significant differences were detected in erythrocyte AchE activity between control subjects and AD patients.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Erythrocyte membrane fluidity; Laurdan; Mild Cognitive Impairment; Oxidative stress

Year:  2019        PMID: 31648010     DOI: 10.1016/j.exger.2019.110754

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  2 in total

1.  Infrared Spectroscopic Study of Multi-Component Lipid Systems: A Closer Approximation to Biological Membrane Fluidity.

Authors:  Maria C Klaiss-Luna; Marcela Manrique-Moreno
Journal:  Membranes (Basel)       Date:  2022-05-20

Review 2.  Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease.

Authors:  Amy H R Wood; Helen F Chappell; Michael A Zulyniak
Journal:  Eur J Nutr       Date:  2021-08-15       Impact factor: 5.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.